Journals / Journal of the Turkish-German Gynecological Association / 2013 / Cilt: 14 - Sayı: 4

Polikistik over sendromu ve tiroid dışı hastalık sendromu arasında bir bağlantı var mı?

Is there a link between polycystic ovary syndrome and non-thyroidal illness syndrome?

Pages
216–220
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, NTIS was not observed in ei-ther group.Conclusion: Thyroid function abnormalities could be observed inPCOS; however, NTIS was not noted in the present study despite theinflammatory state of the PCOS patients.(J Turkish-German Gynecol Assoc 2013; 14: 216-20)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study was to determine the frequencyof non-thyroidal illness syndrome (NTIS) in patients with polycysticovary syndrome (PCOS).Material and Methods: During a 6-month period, 52 patients withPCOS were recruited for this cross-sectional study.
📊
Key Findings & Data:The control groupincluded 68 age-matched female volunteers.
💡
Conclusion & Impact:However, NTIS was not observed in ei-ther group.Conclusion: Thyroid function abnormalities could be observed inPCOS; however, NTIS was not noted in the present study despite theinflammatory state of the PCOS patients.(J Turkish-German Gynecol Assoc 2013; 14: 216-20)
🔬Design:Research Article
📍Scope:2013 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of this study was to determine the frequencyof non-thyroidal illness syndrome (NTIS) in patients with polycysticovary syndrome (PCOS).Material and Methods: During a 6-month period, 52 patients withPCOS were recruited for this cross-sectional study. The control groupincluded 68 age-matched female volunteers. Serum free triiodothyro-nine (fT3), free thyroxine (fT4), thyroid stimulating hormone (TSH),anti-thyroperoxidase antibody (anti-TPO Ab), and anti-thyroglobulinantibody (anti-Tg Ab) were measured.Results: The TSH level in the PCOS patients and controls did not dif-fer significantly (1.9±1.2 μIU/mL vs. 1.8±0.9 μIU/mL, p>0.05). SerumfT3 and fT4 levels in the controls were significantly lower than thosein the PCOS patients (fT3: 2.7±0.3 pg/mL vs. 2.9±0.3 pg/mL, p=0.02;fT4: 1.0±0.1 ng/dL vs. 1.1±0.1 ng/dL, p=0.03). The Hs-CRP (high-sen-sitivity C-reactive protein) level in the PCOS patients was significantlyhigher than in the controls (3.5±4.9 mg/L vs. 1.7±2.7 mg/L, p=0.03).A statistically significant relationship was observed between Hs-CRPand fT4 (r=0.245, p=0.015). However, NTIS was not observed in ei-ther group.Conclusion: Thyroid function abnormalities could be observed inPCOS; however, NTIS was not noted in the present study despite theinflammatory state of the PCOS patients.(J Turkish-German Gynecol Assoc 2013; 14: 216-20)

Özet

Amaç: Bu çalışmanın amacı, polikistik over sendromu (PKOS) olan hastalarda tiroid dışı hastalık sendromunun (NTIS) sıklığını tespit et- mektir. Gereç ve Yöntemler: PKOSlu 52 hasta 6 aylık bir dönemde bu ke- sitsel çalışmaya alındı. Kontrol grubuna yaş uyumlu 68 gönüllü kadın dahil edildi. Serum serbest triyodotironin (sT3), serbest tiroksin (sT4), tiroid uyarıcı hormon (TSH), anti-tiroperoksidaz antikoru (anti-TPO Ab) ve anti-tiroglobulin antikoru (anti-Tg Ab ) ölçüldü. Bulgular: PKOS hastalarında ve kontrol grubunda TSH düzeyinde (1.9±1.8 vs. 1.2 μIU/mL±0.9 μIU/mL, p>0.05) anlamlı fark yoktu. Kont- rol grubunda serum sT3 ve sT4 düzeyleri PKOS hastalarınınkinden anlamlı olarak daha düşüktü (fT3: 2.7±0.3 pg/mL vs. 2.9±0.3 pg/mL, p=0.02; fT4: 1.0±0.1 ng/dL vs. 1.1±0.1 ng/dL, p=0.03). Hs-CRP (yük- sek hassas C-reaktif protein) ve sT4 arasında istatistiksel olarak an- lamlı ilişki gözlendi (r=0.245, p=0.015). Ancak NTIS iki grupta da göz- lenmedi. Sonuç: Tiroid fonksiyon bozuklukları PKOSta gözlenebilir ancak PKOS hastalarındaki inflamatuar duruma rağmen bu çalışmada NTIS tespit edilmedi. (J Turkish-German Gynecol Assoc 2013; 14: 216-20) Anahtar kelimeler:

🔖

Cite This Article

ŞAHİN, M., KARAKÖSE, M., ÇAKAL, E., GİNİŞ, Z., DELİBAŞI, T., SAYKİ, M. A., TOPALOĞLU, O. (2022). Polikistik over sendromu ve tiroid dışı hastalık sendromu arasında bir bağlantı var mı?. Journal of the Turkish-German Gynecological Association, Cilt: 14 - Sayı: 4, 216–220. https://ajindex.com/articles/567601

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1999
  2. [CrossRef] Ehrmann DA, Bames RB, Rosenfild RL, Cavaghan MK, Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 1999
  3. [CrossRef] Orio F Jr, Palomba S, Spinelli L, Cascella T, Tauchmanova L, Zullo F, et al. The cardiovascular risk of young women with polyc- ystic ovary syndrome: an observational, analytical, prospective case-control study. J Clin Endocrinol Metab 2004
  4. [CrossRef] Diamanti-Kandarakis E, Palioniko G, Alexandraki K, Bergiele A, Koutsouba T, Bartzis M. The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ova- rian syndrome and its association with plasma PAI-1 levels. Eur J Endocriol 2004
  5. [CrossRef] Boulman N, Levy Y, Leiba R, Shachar S, Linn R, Zinder O, et al. Increased C-reactive protein levels in the polycystic ovary syndro- me: a marker of cardiovascular disease. J Clin Endocrinol Metab 2004
  6. [CrossRef] Talbott EO, Zborowski JV, Boudreaux MY, McHugh-Pemu KP, Sutton-Tyrrell K, Guzick DS. The relationship between C-reactive protein and carotid intima-media wall thickness in middle-aged women with polycystic ovary syndrome. J Clin Endocrinol Metab 2004
  7. [CrossRef] Diamanti-Kandarakis E, Piperi C, Kalofoutis A, Creatsas G. Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 2005
  8. [CrossRef] Diamanti-Kandarakis E, Spina G, Kouli C, Migdalis I. Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy. J Clin Endocrinol Metab 2001
  9. [CrossRef] Alexander RW. Inflammation and coronary artery disease. N Engl J Med 1994
  10. [CrossRef] Wilson PW, Kannel WB, Silbershatz H, D’Agostino RB. Clustering of metabolic factors and coronary heart disease. Arch Intern Med 1999
  11. [CrossRef] Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K, et al. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 2004
  12. [CrossRef] Lee CD, Folsom AR, Nieto FJ, Chambless LE, Shahar E, Wolfe DA. White blood cell count and incidence of co